持续的贫困,血糖控制和不良的COVID-19结果:使用真实世界的数据进行了一项回顾性研究
Shiori Tanaka1, Shanquela Williams2, Li Zhang3
1Department of Medicine, Division of Internal General Medicine and Population Science, University of Alabama at Birmingham, 701 19th Street South, Birmingham, AL, 35294, USA.
BMC public health
|December 7, 2025
概括
生活在持续贫困地区和低血糖控制独立增加COVID-19风险. 这些因素与更高的住院,ICU入院和死亡率有关,强调需要有针对性的干预措施.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 健康差异 在健康上的差异
背景情况:
- COVID-19大流行揭示了与社会经济因素和糖尿病等慢性疾病相关的重大健康差异.
- 持续的贫困地区,定义为长期的经济贫困,可能会加剧健康风险,特别是对于糖尿病患者和血糖控制不良的人来说.
研究的目的:
- 调查居住在持续贫困地区,糖尿病患者的纵向血糖控制和COVID-19不良结果之间的独立和联合关联.
- 利用现实世界的电子健康记录数据进行全面分析.
主要方法:
- 来自一个大型学术卫生系统的3681名COVID-19患者的电子健康记录的回顾性分析.
- 根据居住在持续贫困人口普查区域和糖尿病状况/血糖控制 (包括未诊断和控制不良的T2DM) 的患者分类.
- 贝叶斯的多变量逻辑回归模型被用来评估关联,控制人口和社会风险因素.
主要成果:
- 居住在持续贫困地区的患者患病率增加了住院 (OR 1.28),ICU入院 (OR 1.40) 和死亡率 (OR 1.50).
- 没有诊断出糖尿病的个体住院几率 (OR3.05) 和死亡率 (OR1.96) 显着更高.
- 低血糖控制,特别是未诊断的糖尿病,成为严重的COVID-19结果的关键风险因素.
结论:
- 居住在持续的贫困人口普查区和血糖控制不佳是COVID-19不良结果的独立风险因素.
- 在持续贫困地区,针对性地管理血糖控制和积极的预防策略对于减轻严重的COVID-19和长期COVID后果至关重要.
相关概念视频
Overview of Carbohydrate Metabolism
3.2K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
3.2K
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Hypoglycemia and Glucagon
778
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
778
Diabetes: Management and Pharmacotherapy
848
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
848


